Can breathing and relaxation exercises ease emotional burden of chronic cancer?
NCT ID NCT07236021
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests two programs designed to help people recently diagnosed with chronic cancer (like metastatic breast, colorectal, or multiple myeloma) manage their emotions. One program is a guided self-help course with weekly phone support from a psychologist; the other adds group sessions. The study will check if these programs are practical, acceptable, and not too burdensome for patients. It involves 30 participants and focuses on feasibility, not yet on proving the programs work.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Guided self-help intervention (breathing exercises, relaxation, hypnosis, psychoeducation) with weekly psychologist calls
- What this could lead to
- If this works, it could provide a practical, low-cost way to help people with chronic cancer manage emotional distress and improve quality of life.
- What could go wrong
- This is a very small pilot study (30 people) testing feasibility, not effectiveness. It may not show clear benefits, and results may not apply to all cancer patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
H.U.B Institut Jules Bordet
RECRUITINGBrussels, Brussels Capital, 1070, Belgium
-
Institut Jules Bordet, Hôpital universitaire de Bruxelles
NOT_YET_RECRUITINGBrussels, Anderlecht, 1070, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo outsmart resistant myeloma?
- Real-world data on multiple myeloma immunotherapies could reshape monitoring and improve survival
- Could an ALS drug clear the fog of chemo brain?
- Immune cell 'Fitness' may predict success of advanced myeloma therapies in older patients
- Gene clues may unlock new treatments for bone marrow cancer
- Study reveals why immunotherapy works differently in liver, lung, and brain tumors